Watching Soligenix, Inc.; Zacks Small-Cap Research Sets $3.50 Price Valuation; Says This Model Is Highly Dependent Upon Continued Clinical Success Of The Company's Pipeline And Will Be Adjusted Accordingly Based Upon Future Clinical Results
Portfolio Pulse from Happy Mohamed
Zacks Small-Cap Research has set a price valuation of $3.50 for Soligenix, Inc. The valuation model is highly dependent on the continued clinical success of the company's pipeline and will be adjusted based on future clinical results.
July 19, 2023 | 3:05 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Zacks Small-Cap Research's price valuation of $3.50 for Soligenix, Inc. is contingent on the company's continued clinical success. Future adjustments will be made based on clinical results.
The price target set by Zacks Small-Cap Research is a significant factor that could influence the stock price of Soligenix, Inc. However, the target is contingent on the company's continued clinical success, which introduces a degree of uncertainty. Therefore, the short-term impact on the stock price is neutral until further clinical results are available.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100